Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Change in Receivables (2022 - 2025)

Historic Change in Receivables for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to $27121.0.

  • bioAffinity Technologies' Change in Receivables rose 11010.25% to $27121.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$878178.0, marking a year-over-year decrease of 41821.73%. This contributed to the annual value of $327530.0 for FY2024, which is 20519.13% up from last year.
  • As of Q3 2025, bioAffinity Technologies' Change in Receivables stood at $27121.0, which was up 11010.25% from -$541875.0 recorded in Q2 2025.
  • In the past 5 years, bioAffinity Technologies' Change in Receivables registered a high of $472017.0 during Q2 2024, and its lowest value of -$541875.0 during Q2 2025.
  • In the last 4 years, bioAffinity Technologies' Change in Receivables had a median value of $559.0 in 2022 and averaged -$44339.4.
  • As far as peak fluctuations go, bioAffinity Technologies' Change in Receivables crashed by 4294901.61% in 2023, and later soared by 5788048.33% in 2024.
  • bioAffinity Technologies' Change in Receivables (Quarter) stood at $559.0 in 2022, then crashed by 42949.02% to -$239526.0 in 2023, then grew by 21.53% to -$187964.0 in 2024, then skyrocketed by 114.43% to $27121.0 in 2025.
  • Its Change in Receivables was $27121.0 in Q3 2025, compared to -$541875.0 in Q2 2025 and -$175460.0 in Q1 2025.